Tag: Eli Lilly

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Eli Lilly

Who's Next To Join Tesla, Broadcom In $1 Trillion Club? Over 50% Say The World's Biggest Retailer

Added to Collection on: 2024-12-18 20:32:19

Tags for this article:

Fabless semiconductor companies
Publicly traded companies
Nvidia
Broadcom
Berkshire Hathaway
Eli Lilly
Tesla Inc.
Apple Inc.
meta platforms
Alphabet Inc.
Market capitalization
Megacap stock

Click the tags to see associated articles and topics

View Article Details
Eli Lilly (LLY) Stock Sinks As Market Gains: What You Should Know - Zacks

Added to Collection on: 2024-12-24 23:54:27

Tags for this article:

Financial ratios
PEG ratio
LLY
Price?earnings ratio
Eli Lilly and Company
Eli Lilly
Zacks
Fundamental analysis
Investment
Lilly
Pharmaceutical industry
Valuation
DOW JONES INDUSTRIAL AVERAGE INDEX
S&P 500 INDEX - CBOE

Click the tags to see associated articles and topics

View Article Details
2 Pharmaceutical Growth Stocks to Buy Now and Hold for Decades - The Globe and Mail

Added to Collection on: 2024-12-28 13:32:13

Tags for this article:

PEPTIDE THERAPEUTICS
Peptide hormones
Eli Lilly and Company
Research and development in the United States
Novo Nordisk
GLP-1 receptor agonist
Semaglutide
Tirzepatide
Eli Lilly
Anti-obesity medication
Insulin
Cagrilintide/semaglutide

Click the tags to see associated articles and topics

View Article Details
Sleep apnea device makers end year with mix performance despite GLP-1 concerns

Added to Collection on: 2024-12-31 18:04:54

Tags for this article:

Sleep disorders
Sleep apnea
GLP-1 receptor agonist
ResMed
Tirzepatide
Eli Lilly and Company
Eli Lilly
Philips
LivaNova

Click the tags to see associated articles and topics

View Article Details
Eli Lilly, Novo Nordisk Went Head-to-Head on Weight-Loss Drugs in 2024. There's a Clear Winner.

Added to Collection on: 2024-12-31 14:53:12

Tags for this article:

PEPTIDE THERAPEUTICS
Peptide hormones
GLP-1 receptor agonist
Eli Lilly and Company
Novo Nordisk
Cagrilintide/semaglutide
Tirzepatide
Glucagon-like peptide-1
Anti-obesity medication
Eli Lilly

Click the tags to see associated articles and topics

View Article Details
Lilly provides update on 2024 revenue guidance, announces 2025 revenue guidance

Added to Collection on: 2025-01-14 20:06:00

Tags for this article:

Eli Lilly and Company
Research and development in the United States
Science and technology in the People's Republic of China
Tirzepatide
Forward-looking statement
Pharmaceutical industry
Eli Lilly

Click the tags to see associated articles and topics

View Article Details
2 Healthcare Stocks You Can Buy Right Now Before They Surge Even Higher

Added to Collection on: 2025-01-24 15:54:33

Tags for this article:

Research and development in the United States
Eli Lilly and Company
Vertex Pharmaceuticals
Eli Lilly
Pharmaceutical industry
Tirzepatide
Suzetrigine

Click the tags to see associated articles and topics

View Article Details
Credissential Futureproofs Antenna Platform with Quantum Encryption - TipRanks.com

Added to Collection on: 2025-02-06 18:17:15

Tags for this article:

Null
Suncor Energy
Eli Lilly
Credissential Inc.
Axiom Capital Advisors, Inc.

Click the tags to see associated articles and topics

View Article Details
Sr Principal Machine Learning Engineer - Wolseley Canada | Built In

Added to Collection on: 2025-02-19 20:21:14

Tags for this article:

Cybernetics
Big data
Formal sciences
Computational neuroscience
Learning
Artificial intelligence
Eli Lilly and Company
Analytics
Eli Lilly
Business analytics
Artificial general intelligence
Machine learning

Click the tags to see associated articles and topics

View Article Details
ELI LILLY & Co SEC 10-K Report - TradingView

Added to Collection on: 2025-02-19 15:37:12

Tags for this article:

Eli Lilly and Company
Research and development in the United States
Eli Lilly
Pharmaceutical industry
Tirzepatide
Risk management
Josiah K. Lilly Sr.
GLP-1 receptor agonist
Eli Lilly & Co.

Click the tags to see associated articles and topics

View Article Details